secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sanara MedTech Inc. (SMTI)
CIK:        0000714256
Form:       8-K
Filed at:   2021-12-28T23:59:59+00:00
Accession:  0001493152-21-032604
Event type: leadership
Sentiment:  positive
Materiality: 0.70
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sanara MedTech appoints Zachary B. Fleming as CEO effective January 1, 2022
---------------------------------------------------------------------------

- Zachary B. Fleming appointed CEO effective Jan 1, 2022; previously Co-COO & President of Surgical Division.
- Base salary raised from $225,000 to $290,000; eligible for annual restricted stock award up to 75% of salary.
- Eligible for annual cash bonus up to 50% of base salary; also receives customary benefits.
- Fleming led surgical division through double-digit revenue growth and COVID-19 challenges.
- Executive Chairman Ron Nixon expressed confidence in Fleming's leadership and strategic vision.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/714256/000149315221032604/0001493152-21-032604-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/714256/000149315221032604/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-21-032604

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer